These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1682458)

  • 41. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bioavailability of isradipine in young and old rats: effect of mode of administration.
    Tse FL; Jaffe JM; Hassell AE; Schran HF
    J Pharm Pharmacol; 1989 Sep; 41(9):657-60. PubMed ID: 2573717
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acyclovir prodrug for the intestinal di/tri-peptide transporter PEPT1: comparison of in vivo bioavailability in rats and transport in Caco-2 cells.
    Thomsen AE; Christensen MS; Bagger MA; Steffansen B
    Eur J Pharm Sci; 2004 Dec; 23(4-5):319-25. PubMed ID: 15567284
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of mucoadhesive microspheres of acyclovir with enhanced bioavailability.
    Tao Y; Lu Y; Sun Y; Gu B; Lu W; Pan J
    Int J Pharm; 2009 Aug; 378(1-2):30-6. PubMed ID: 19465102
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of ageing on the oral absorption of D-xylose in rats: analysis of gastrointestinal disposition.
    Yuasa H; Kawanishi K; Watanabe J
    J Pharm Pharmacol; 1995 Jul; 47(7):576-80. PubMed ID: 8568624
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetic fate of the novel antihypertensive drug naftopidil.
    Peter G; Niebch G; Locher M; Borbe HO
    Arzneimittelforschung; 1991 Sep; 41(9):924-31. PubMed ID: 1796920
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oral absorption of anti-acquired immune deficiency syndrome nucleoside analogues. 2. Carrier-mediated intestinal transport of stavudine in rat and rabbit preparations.
    Waclawski AP; Sinko PJ
    J Pharm Sci; 1996 May; 85(5):478-85. PubMed ID: 8742938
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of chitosan on the bioaccessibility and intestinal permeability of acyclovir.
    Kubbinga M; Augustijns P; García MA; Heinen C; Wortelboer HM; Verwei M; Langguth P
    Eur J Pharm Biopharm; 2019 Mar; 136():147-155. PubMed ID: 30682491
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Active transport of lead-210 by everted segments of rat duodenum.
    Barton JC
    Am J Physiol; 1984 Aug; 247(2 Pt 1):G193-8. PubMed ID: 6465315
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ex vivo permeability experiments in excised rat intestinal tissue and in vitro solubility measurements in aspirated human intestinal fluids support age-dependent oral drug absorption.
    Annaert P; Brouwers J; Bijnens A; Lammert F; Tack J; Augustijns P
    Eur J Pharm Sci; 2010 Jan; 39(1-3):15-22. PubMed ID: 19837159
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nasal absorption of tetraethylammonium in rats.
    Kimura R; Miwa M; Kato Y; Yamada S; Sato M
    Arch Int Pharmacodyn Ther; 1989; 302():7-17. PubMed ID: 2636827
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transport of L-valine-acyclovir via the oligopeptide transporter in the human intestinal cell line, Caco-2.
    de Vrueh RL; Smith PL; Lee CP
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1166-70. PubMed ID: 9732374
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics of acyclovir after intravenous infusion of acyclovir and after oral administration of acyclovir and its prodrug valacyclovir in healthy adult horses.
    Garré B; Shebany K; Gryspeerdt A; Baert K; van der Meulen K; Nauwynck H; Deprez P; De Backer P; Croubels S
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4308-14. PubMed ID: 17846132
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of intestinal carnitine transport in rats.
    Leichter J; Hahn P
    Biol Neonate; 1988; 53(6):367-70. PubMed ID: 3408754
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanisms of aluminum absorption in rats.
    Whitehead MW; Farrar G; Christie GL; Blair JA; Thompson RP; Powell JJ
    Am J Clin Nutr; 1997 May; 65(5):1446-52. PubMed ID: 9129475
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics of acyclovir after single intravenous and oral administration to adult horses.
    Bentz BG; Maxwell LK; Erkert RS; Royer CM; Davis MS; MacAllister CG; Clarke CR
    J Vet Intern Med; 2006; 20(3):589-94. PubMed ID: 16734094
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics and safety of valaciclovir in children with Epstein-Barr virus illness.
    Simon MW; Fish DN; Deeter RG
    Drugs R D; 2002; 3(6):365-73. PubMed ID: 12516939
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Improvement of the oral drug absorption of topotecan through the inhibition of intestinal xenobiotic efflux transporter, breast cancer resistance protein, by excipients.
    Yamagata T; Kusuhara H; Morishita M; Takayama K; Benameur H; Sugiyama Y
    Drug Metab Dispos; 2007 Jul; 35(7):1142-8. PubMed ID: 17446265
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mechanism for increased bioavailability of tacrine in fasted rats.
    Sung JH; Hong SS; Ahn SH; Li H; Seo SY; Park CH; Park BS; Chung SJ
    J Pharm Pharmacol; 2006 May; 58(5):643-9. PubMed ID: 16640833
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Permeation of acyclovir through the intestinal mucosa of the rat: experiments with an in vitro mathematical model].
    Grassi M; Coceani N; Cadelli G; Esposito P
    Boll Chim Farm; 1999 Mar; 138(3):121-8. PubMed ID: 10394707
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.